Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics-Reference-Cited by-同舟云学术

Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics

Published:2016-01 Issue: Volume:137 Page:178-183
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Testa Sophie^ORCID,Tripodi Armando,Legnani Cristina,Pengo Vittorio,Abbate Rosanna,Dellanoce Claudia,Carraro Paolo,Salomone Luisa,Paniccia Rita,Paoletti Oriana,Poli Daniela,Palareti Gualtiero

Publisher

Elsevier BV

Subject

Hematology

Reference19 articles.

1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009

2. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N. Engl. J. Med.,2011

3. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N. Engl. J. Med.,2011

4. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N. Engl. J. Med.,2013

5. Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study;Samama;J. Thromb. Thrombolysis,2013

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events;International Journal of Cardiology;2024-12

2. Rapid Determination of Rivaroxaban by Using Terahertz Metamaterial Biosensor;Photonics;2024-08-29

3. Apixaban plasma concentrations before and after catheter ablation for atrial fibrillation;PLOS ONE;2024-07-31

4. Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer;British Journal of Cancer;2024-06-11

5. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study;Blood Advances;2024-04-10